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Abstract
Macrocyclic lactones (MLs) represent the major drug class for control of parasitic infections in humans and animals.
However, recently reports of treatment failures became more frequent. In addition to human and ruminant parasitic
nematodes this also is the case for the horse-nematode Parascaris equorum. Nevertheless, to date the molecular basis of ML
resistance is still not understood. Unspecific resistance mechanisms involving transporters such as P-glycoproteins (Pgps)
are expected to contribute to ML resistance in nematodes. Here, complete sequences of two P. equorum Pgps were cloned
and identified as orthologs of Caenorhabditis elegans Ppg-11 and an unnamed Caenorhabditis briggsae Pgp designated as
Pgp-16 using phylogenetic analysis. Quantitative real-time PCR was used to compare expression between tissues.
Significantly higher PeqPgp-11 expression was found in the gut for both genders, whereas for PeqPgp-16 the body wall was
identified as predominant expression site. Furthermore, Pgps were analyzed regarding their participation in resistance
development. Using SeqDoC analyses, Pgp-sequences of P. equorum populations with different ML susceptibility were
compared. This approach revealed three single nucleotide polymorphisms (SNPs) causing missense mutations in the
PeqPgp-11 sequence which correlated with decreased ML susceptibility. However, no resistance associated differences in
mRNA expression levels were detected between embryonated eggs of these populations. In contrast, comparison of two
pre-adult groups with different ivermectin (IVM) susceptibility revealed the presence of the three SNPs and in addition
statistically significant PeqPgp-11 overexpression in the group of worms with reduced susceptibility. These results indicate
that Pgp-11 might be involved in IVM resistance in P. equorum as it shows increased expression in an IVM exposed life-cycle
stage of an IVM resistant population as well as occurrence of putatively resistance associated SNPs in populations with
reduced IVM susceptibility. These SNPs are promising diagnostic candidates for detection of ML resistance with potential
also for other parasitic nematode species.
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Introduction
For decades macrocyclic lactones (MLs) have been used for the
treatment and control of infections with endoparasitic nematodes
and ectoparasitic arthropods in human and veterinary medicine
[1]. Due to their extensive use, ML resistance has evolved in
several parasites, as it also has been described for the two other
major families of broad-spectrum anthelmintics routinely used in
livestock, the benzimidazoles (BZ) and the agonists of the nicotinic
acetylcholine receptor such as the tetrahydropyrimidine pyrantel
and the imidazothiazole levamisole [2,3,4]. Even though the
prevalence of ML resistant nematode populations increases, the
resistance mechanisms remain largely unclear. Several possible
mechanisms are discussed, including the activity of ATP-binding-
cassette (ABC)-transporters, in particular P-glycoproteins (Pgps)
[5]. Pgps are located in the apical cell-membrane, act as ATP-
dependent transporters for hydrophobic xenobiotics such as
anthelmintics and decrease the concentration of the drugs at their
target sites [6]. This effect finally prohibits an efficient treatment.
A correlation between Pgps and resistance to both BZs and MLs
has already been described for some nematodes [7,8,9,10]. For
Caenorhabditis elegans, 14 Pgp genes and one pseudogene have been
published [11,12] or annotated in Wormbase and use of a Pgp-3
deficient strain demonstrated that this protein decreases sensitivity
to colchicine and chloroquine [7]. In contrast, the loss of Pgp-1
results in hypersensitivity to heavy metals [13]. More recently, an
overexpression of five Pgps was demonstrated in an ivermectin
(IVM) resistant C. elegans strain [14]. Furthermore, eight Pgps were
reported in Brugia malayi [15], nine full or partial sequences in
Haemonchus contortus [10,16,17,18], at least two Pgp cDNAs in
cyathostomins [19], eleven partial sequences in Teladorsagia
circumcincta [20] and two full-length Pgp-encoding sequences in
Onchocerca volvulus [17,21]. However, there are currently no
database entries for Parascaris equorum Pgps although there are
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several P. equorum populations known to show reduced suscepti-
bility or even resistance against IVM as reported from various
countries in Europe and the Americas [22].
Due to its global distribution, high prevalence and severe
pathogenicity, the nematode P. equorum is one of the most
important parasitic pathogens of equines. In particular in foals
and yearlings parascarosis can cause severe illness and even death.
Infected horses can show several clinical signs, depending on the
worm burden and ranging from nasal discharge and coughing, to
a bad general condition and ceased growth, up to lethal intestinal
obstruction and/or rupture. Treatment is generally carried out
with BZs, tetrahydropyrimidines or MLs. In this context, P.
equorum takes an exceptional position as it is the dose-limiting
species for all currently available broad-spectrum anthelmintics in
horses except for the tetrahydropyrimidines [23]. Moreover, due
its high pathogenicity for foals and yearlings, many horse breeders
deworm this age group more than six times a year [24]. Therefore,
it is not surprising that decreased susceptibility to anthelmintics in
P. equorum is rapidly spreading and currently has become a key
health concern for foals and young horses on many stud farms.
This emphasizes the importance to decipher resistance mecha-
nisms and to identify markers which can be used to detect
developing resistance at an early stage. However, the number of
routine molecular diagnostic tests for detection of anthelmintic
resistance is restricted to the BZs, where resistance markers could
already be identified and evaluated. Three single nucleotide
polymorphisms (SNPs) which cause changes at codons 167, 198 or
200 in the b-tubulin isotype 1 gene are present in many BZ-
resistant nematode populations [5]. In contrast, results for the MLs
are more diverse: studies of the T. circumcincta and H. contortus
glutamate-gated chloride channel (GluCl) subunits revealed no
changes of the target genes which might be responsible for
anthelmintic resistance [25,26]. On the other hand, mutations of
the GluCl-subunits of Cooperia oncophora have been shown to cause
a significant decrease in sensitivity to glutamate and IVM [27],
although the identified SNPs have not yet been reported in any
IVM resistant field isolates since then. Results appear to be
similarly variable for the Pgps where a high frequency of
polymorphisms in pgp-9 of T. circumcincta was demonstrated but
no resistance associated coding SNPs for the investigated region
were identified [20]. It has also been shown that the restriction
patterns of H. contortus pgp-2 differ between IVM susceptible and
IVM resistant populations [10]. Additionally, slightly increased
pgp-2 and pgp-9 mRNA expression levels were demonstrated in
resistant isolates of H. contortus [10,28] as well as T. circumcincta pgp-
9 [20] and C. elegans pgp-1 and pgp-2 [29]. In contrast, a decreased
expression was shown for pgp-1 in H. contortus.
The techniques to detect ML resistance in P. equorum
populations are very limited. Since there are no laboratory hosts
for P. equorum and in vitro culture is very labor intensive and only
possible for a short time, molecular resistance markers would help
to develop a particularly attractive diagnostic tool. Currently, the
only option to diagnose resistance for this parasite is the fecal egg
count reduction test (FECRT); however this test has not been
validated for P. equorum yet. Moreover, this test provides no
information regarding the proportion of resistant individuals in the
population and has a high risk to be false negative when the
frequency of resistant parasites is still low [30]. Additionally, results
are only available after two weeks.
In order to find predictive molecular markers, parasites have to
be screened for genetic changes. As IVM is a known substrate of
mammalian Pgps [31], the objective of this work was to identify
and characterize P. equorum Pgps. Remarkably, SNPs in non-drug
target genes potentially involved in the development of ML
resistance were identified by comparing the coding sequences for
specific Pgps between several populations with different IVM
susceptibility. Furthermore, increased Pgp expression levels were




Adult P. equorum worms were obtained from a necropsy of
experimentally infected horses which were euthanized by bleeding
through opening the carotid artery immediately following captive
bolt stunning. Worms were stored at 280uC until use. Experi-
ments were conducted in accordance with the German law
(Tierschutzgesetz) and the European Union directive 2010/63/
EU regarding animal welfare and approved by the Landesamt fu¨r
Verbraucherschutz und Lebensmittelsicherheit (LAVES) under
the reference number 33.9-42502-05-07A499. Fecal samples were
collected rectally from horses of six stud farms and were sent in the
institute for routine diagnostic examinations. The remainders of
the samples not used for diagnostic purposes were used for ascarid
egg collection and thus no permit for sample collection was
required according to current legislation. Two populations
(collected from stud-farm A and B-1) were susceptible against
ML and treatment with IVM resulted in complete elimination of
P. equorum eggs in feces two weeks after treatment. From stud farm
A eggs were collected in two sequential years showing no
difference in ML susceptibility in vivo. For foals of stud farm B,
no reduction but even an increase of the fecal egg count was found
one year later when routine diagnostic controls after deworming
with IVM were carried out by Flotac for 33% of the foals (n = 9).
For this reason, eggs from the same stud farm but collected at
different points of time were classified as two populations in further
investigations (B-1 and B-2). Besides eggs from farm B-2, the P.
equorum population on an additional farm (E) did show decreased
IVM susceptibility at the FECRT (i.e. FECR 0%; n= 9). Samples
of this farm were also taken in two different years with no hints of
changes in ML susceptibility in vivo. Two other stud-farms (C and
D) were not definitely classified being either IVM susceptible or
having a decreased susceptibility as they just showed initial signs of
decreased ML susceptibility: Repeated treatment with MOX was
not successful for 17% of the foals (n = 23) of stud farm D showing
a FECR of 89.6% as determined by Flotac 19 days after
treatment. At stud farm C, 22% of the examined foals (n = 23)
were still highly positive for P. equorum in the fecal examination 20
days after deworming with IVM (52–200 eggs per gram).
Unfortunately, no pre-treatment data were available for this farm,
so determination of the FECR was not possible. Ages of the
examined foals ranged from four to eight months. Eggs were
isolated from feces by sieving with different mesh sizes (120 mm
and 80 mm, respectively) followed by sedimentation and flotation
with saturated saline before eggs were diluted with tap water and
stored in ventilated cell culture bottles at 4uC.
For quantitative reverse transcriptase-PCR, adult and pre-adult
worms with unknown treatment of the infected horses were
collected from a slaughterhouse in Slomniki near Krako´w, Poland
with permission by the slaughterhouse manager to isolate and use
the ascarids for further analyses. A group of pre-adult worms
which were suspected to be ML resistant was obtained from Prof.
Bretislav Koudela (University of Veterinary and Pharmaceutical
Sciences Brno, Czech Republic). These worms were collected
from the small intestine of a three month old foal kept on a farm
where horses were regularly treated with IVM and where ML
resistance was suspected due to the persistence of egg shedding
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post treatment (though no FECRT available). Pre-adult worms
had a mean length of approximately 10 cm which suggests that the
animal was infected within the first days after birth [32]. This
group was compared with a randomly selected, size-matched
group of worms from the slaughterhouse in Krako´w.
Cloning and Sequencing of PeqPgps
Total RNA was extracted from adult female worms using
peqGOLD TriFastTM (Peqlab), following the manufacturer’s
instructions, after homogenization with a TissueRuptor (Qiagen).
RNA was stored at 280uC until use.
Contaminating genomic DNA was eliminated by digestion with
DNase I (Fermentas). First strand cDNA synthesis was performed
with 160 ng of total RNA using the RevertAidTM Premium
Reverse Transcriptase Kit (Fermentas) and random hexamer
primers according to the manufacturer’s protocol with incubation
at 22uC for 5 min followed by 50uC for 30 min, 60uC for 30 min
and 85uC for 5 min. A nested PCR with degenerated primers
(Table S1) [18] was performed to generate an initial PCR product
of the internucleotide binding domain (IBD). The reaction
contained 2.5 ml AccuPrimeTM Buffer I (with dNTPs), 1 mM of
each forward and reverse primers, 0.5 ml cDNA, 0.5 ml AccuPri-
meTM Taq DNA Polymerase (Invitrogen) and 16.5 ml dH2O. After
an initial denaturation at 94uC for 2 min, 40 cycles with 94uC for
15 s, 55uC for 30 s and 72uC for 1 min were performed. Gel-
purified PCR products were cloned into the pCR4 TOPO vector
(Invitrogen). Sequencing was carried out by GATC Biotech
(Konstanz). Gene specific primers (Table S1) were designed from
the sequenced fragments for RACE PCR (5’/3’ RACE Kit, 2nd
Generation, ROCHE), which allowed amplification of the
respective full-length cDNA sequences.
Phylogenetic Analyses
For phylogenetic analysis, nucleic acid sequences were translat-
ed into amino acid sequences and these were compared with Pgp
amino acid sequences of other nematodes as well as sequences of
Mus musculus, Schistosoma mansoni, Pediculus humanus corporis, Drosophila
melanogaster, Mytilus galloprovincialis and Mytilus californianus as
outgroup (for Genbank-accession numbers see Table S5).
Sequences were first aligned with ClustalX2 using default
parameters. The alignment was then analyzed with Prottest 3.0
[33,34] to identify the optimal amino acid substitution model. The
number of substitution rate categories for this analysis was set to 8.
Finally, a maximum likelihood tree was calculated using PhyML
3.0.1 [35,36] with 8 substitution rate categories and the LG+G+F
model [37]. Both, nearest neighbor interchange (NNI) and subtree
pruning and regraftment (SPR) moves were allowed. Calculations
were started with one neighbor joining and five random trees to
avoid trapping of the iterative optimization process in a local
maximum of the likelihood function. Both the Shimodaira-
Hasegawa [SH] approximate likelihood test and the Baysian
transformation of the approximate likelihood ratio test for branch
support were calculated. The best tree was finally visualized using
MEGA5.
SeqDoC Analyses
The six P. equorum populations with different ML susceptibility
were compared regarding their Pgp cDNA sequences. For each
population at least to independently obtained samples were
analyzed. For RNA isolation approximately 5000 P. equorum eggs
were crushed in tubes containing Buffer RL1 (Macherey & Nagel)
and ceramic beads of 0.4 to 0.6 mm (innuSpeed Lysis Tube S,
Analytik Jena, Germany) with a Speed Mill homogenizer (Analytik
Jena). Afterwards, RNA was isolated using the NucleoSpin RNA
XS-Kit (Macherey & Nagel) including a DNase treatment step
during isolation. Additionally, RNA of individual pre-adult
putatively resistant (Czech Republic worms) and randomly
selected worms (from slaughterhouse in Krakow) was extracted
with TriFastTM (Peqlab). RNA was reverse transcribed into cDNA
with RevertAidTM Premium First Strand cDNA Synthesis Kit
(Thermo Scientific) according to the manufacturer’s protocol. RT-
PCR was performed in a 10 ml reaction (1 ml AccuPrimeTM Buffer
I, 0.5 mM forward and reverse primers, 1 ml cDNA, 0.25 ml
AccuPrimeTM Taq DNA polymerase (Invitrogen) and 4.75 ml
dH2O. For each Pgp sequence, eight pairs of gene-specific primer
pairs covering the whole open reading frame with about 100 bp
overlap between amplicons were used (Table S2). Cycling
conditions were first an initial denaturation at 94uC for 2 min,
then 40 cycles with 94uC for 15 s, 55uC for 30 s and 72uC for 45 s.
PCR fragments of about 700 bp were excised from agarose gels,
purified and directly sequenced using the gene-specific forward
primer. For each of the eight overlapping fragments, sequence
chromatogram files were entered into the SeqDoC web platform
[38]. The detected SNPs were mapped to the full-length cDNA
sequence and translated to discriminate silent and missense
mutations and to find any potential amino acid changes. The
chemical distance between these substitutions was determined
according to Grantham [39]. Additionally, chromatogram files of
sequences containing SNPs potentially involved in ML resistance
were exported to GraphPad Prism 5.0.3 and area under curve of
fluorescence signals detected for the corresponding bases was
calculated.
Three-dimensional Modelling of Pgp-11
The webserver ESyPred2d was used to calculate a tertiary
structure model using a 3D model of murine Pgp-1 deposited in
PDB with accession no. 3G5U_A [40] as template. The model
obtained for P. equorum Pgp-11 was visualized using Jmol, an open-
source Java viewer for chemical structures in 3D (http://www.
jmol.org/).
Real-time RT-PCR of P. equorum Eggs from Different
Populations
For comparison of P. equorum Pgp expression levels in the
different populations, quantitative RT-PCR was conducted.
Embryonated P. equorum eggs of populations A-E were homoge-
nized and RNA was subsequently extracted with the innuPREP
RNA Mini Kit (Analytik Jena) which already includes a genomic
DNA removal step. RNA purity and amount were measured with
a Take3 plate in a Synergy plate reader (Biotek). Due to the very
small amount of RNA isolated from eggs, control of RNA integrity
on the BioanalyzerH was not possible. For each population
approximately 80 ng RNA were used for the following cDNA
synthesis with QuantiTect Reverse Transcription Kit (Qiagen) per
20 ml reaction with another integrated genomic DNA removal
step. Real-time RT-PCR was performed in a total reaction of
50 ml with 25 ml GoTaq qPCR Master Mix (Promega), 0.2 mM
each of a forward and reverse gene-specific primer for the
particular P. equorum Pgp (Table S3), 18 ml dH20 and 5 ml of
template on white 96-well plates sealed with BZO adhesive optical
film (Biozym, Germany). Reactions were carried out under the
following PCR cycling conditions: After an initial denaturation
step at 95uC for 2 min, 50 cycles with 95uC for 15 s, 59uC for 30 s
and 72uC for 30 s were performed on a CFX96 Thermal Cycler
(Biorad). Melting curves were recorded between 60uC and 95uC.
Two biological replicates (from different sampling occasions) were
analyzed for each of the five populations; for each replicate two
cDNA syntheses were performed and each sample was analyzed in
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duplicates on the same plate (technical replicates). At least four
independent PCR runs were performed, providing a minimum of
eight replicates. Three RNAs, namely actin, glyceraldehyde 3-
phosphate dehydrogenase (gpd-1) and 18S rRNA, were used as
reference genes for normalization according to MIQE guidelines
[41]. Serial dilutions of plasmid DNA (from 4 to 46106 copies per
reaction) were used to obtain standard curves and calculate
reaction efficiencies. Pgp gene expression was normalized to the
geometric mean of the signals obtained from the reference genes as
described by Hellemans et al. [42].
Real-time RT-PCR of Different P. equorum Tissues
A real-time RT-PCR was conducted to compare pgp-11 and
pgp-16 mRNA expression between tissues. For this purpose, adult
male and female worms were collected from the slaughterhouse
(Krako´w, Poland) and stored at 280uC in RNAlater (Sigma).
Worms were dissected and from a middle body part, uterus,
intestine and body wall of six female worms and the intestine and
body wall of six male worms were collected. Unfortunately, clean
preparation of testes was not possible with the material preserved
in RNAlater. Homogenization of body wall and uterus was carried
out in tubes containing ceramic beads of 1.4–1.6 mm, while the
intestine was homogenized in tubes with ceramic beads with a size
of 0.4–0.6 mm (Analytik Jena, Germany). RNA isolation, cDNA-
synthesis and real-time RT-PCR were performed as described
above. To ensure that no RNA degradation would influence
results, RNA integrity was confirmed with the Bioanalyzer 2100
(Agilent Technologies). Only RNA preparations with a RNA
integrity number (RIN) .8.3 were used.
Real-time RT-PCR of Adult P. equorum Worms after
Incubation with IVM
In order to investigate the influence of a short term incubation
of P. equorum with IVM, adult worms were collected at an abattoir
(Krako´w, Poland), sexed and rinsed with pre-warmed artificial
perienteric fluid (APF) to remove host intestinal contents as
previously described [43]. In brief, APF contained 5 mM MgCl2,
6 mM CaCl2, 24 mM KCl, 23 mM NaCl, 110 mM NaCH3-
COO, 11 mM dextrose, 10 mM Tris and was adjusted to a final
pH of about 7.5 at 37uC. Before IVM-challenge was carried out in
ventilated cell culture flasks, worms were adapted to in vitro
conditions at 37uC in APF for 18 h. Providing 20 ml of APF for
each worm with either IVM (1028 M or 1029 M) or only 1%
DMSO (vehicle control), worms were incubated for 12 h at 37uC.
At a concentration of 1029 M nearly all worms survived the
treatment whereas higher IVM concentrations killed worms before
the end of the incubation time. Therefore, only worms surviving
exposure to 1029 M IVM were used for quantitative analysis of
gene expression, rapidly frozen and stored at 280uC until further
use. Total RNA was extracted from individual female worms using
the TriFast reagent as described above and RNA integrity was
determined with the Bioanalyzer 2100 (RIN .9.1) before cDNA
was synthesized. Further real-time RT-PCR steps were conducted
as described above. Five biological replicates (individual worms)
were analyzed per group and for each RNA preparation of
individual worms, two cDNA syntheses were performed. PCR was
carried out with two technical replicates resulting in at least four
replicates per individual worm.
Comparison of Expression Levels between a Putatively
Resistant and Random Group of P. equorum
Worms of a presumably IVM resistant population were
collected from the small intestine of a foal and directly frozen at
280uC. Samples of a group of pre-adult P. equorum worms with
unknown treatment were collected from the slaughterhouse in
Krako´w, Poland. For gender determination, degenerated primers
for vitellogenin-6 derived from corresponding sequences of Ascaris
suum, C. elegans and C. briggsae (Table S4) were used in an RT-PCR
to differentiate between female and male worms. Relative
expression of pgp-11 and pgp-16 of each group containing five
worms was compared with regard to the state of resistance of
worms in a RT-qPCR. RNA quality was assessed and only RNAs
with RIN .9.1 were used for downstream application. For each
biological replicate, two separate cDNA synthesis were carried out,
followed by two technical replicates for each cDNA.
Results
Sequencing of P. equorum Pgps
RT-PCR using degenerated primers resulted in 12 fragments
localized in the IBDs of Pgps. These products had a size of
approximately 408 bp. Identity of the obtained PCR products was
confirmed by a nested PCR resulting in products of about 345 bp.
Following 5’/3’ RACE starting from two selected partial
sequences allowed obtaining full-length sequences with a length
of 3858 bp and 3855 bp, respectively. For the first sequence, a 5’
spliced leader sequence SL1 [44] was identified upstream of the
open reading frame. Sequences were deposited in the GenBankTM
database with accession no. JX308230 and JX308231. Concep-
tional translation resulted in two putative protein products of 1285
and 1284 amino acids revealing typical, highly conserved Pgp
domains such as two Walker A/P-loops, Walker B motif, Q-loop/
lids, D-loop, H-loops/switch region, ABC transporter signature
motifs as well as two ATP binding sites (Fig. S1). Predicted proteins
have a calculated molecular weight of 141.05 kD and 139.45 kD,
respectively. Phylogenetic analysis by maximum likelihood esti-
mation using the deduced amino acid sequences from the two
putative Pgps of P. equorum and Pgp sequences of several
nematodes including the complete Pgp sets of C. elegans and
Caenorhabditis briggsae (Table S5) revealed that nematode Pgps are
monophyletic and did not evolve from different precursors present
in a common protostomian ancestor. The first P. equorum Pgp
sequence is orthologous to C. elegans Pgp-11 (accession-no.:
NP_495674) (Fig. 1) and was therefore designated as PeqPgp-11.
Blast analyses showed an identity of 37%. The other full-length
sequence has no direct ortholog in the C. elegans Pgp-family, but is
closely related to the Caenorhabditis briggsae CBG12969 sequence
(accession-no.: XP_002630530). In the C. elegans genome, Pgp-3
and Pgp-4 (accession-no.:NP_509901 and NP_001257143) with
an identity of 51% and 49%, respectively, were most closely
related. According to the rules for gene nomenclature in
nematodes [45] it was designated as PeqPgp-16. The most closely
related sequences identified in GenBank were the A. suum Pgp
orthologs MRP-1 (accession-no.: ADY40818) and MRP-3 (acces-
sion-no.:ADY40776) with 92% identity (99% similarity) and 93%
identity (91% similarity) to PeqPgp-11 and PeqPgp-16, respectively.
Single Nucleotide Polymorphisms in P. equorum Pgps
In order to compare the cDNA sequence of the two Pgps
between different P. equorum populations, gene specific primer sets
were used to amplify overlapping fragments of approximately
700 bp covering the complete coding sequences followed by
sequencing and SeqDoC analysis. RNA was isolated from eggs
collected from two sensitive (farms A and B1), two intermediate
(farms C and D) and two populations with severely decreased
susceptibility (farms B2 and E) to MLs. Several single nucleotide
polymorphisms (SNP) could be identified in this way.
Parascaris Equorum: Pgp and Ivermectin Resistance
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For Peqpgp-16 cDNA, the analysis revealed only seven SNPs
(Table S7 and Fig. S1), two of them missense and five silent
mutations, but none of them was consistently present in all
investigated populations with decreased ML susceptibility.
In contrast, the corresponding analysis of the Peqpgp-11 cDNA
revealed 29 polymorphisms by comparing the partial sequences of
all populations (Table S6 and Fig. S1). Fifteen SNPs resulted in a
silent mutation, whereas 14 caused amino acid substitutions. Most
of them were localized in the NH2-terminal part of the first
transmembrane domain region whereas three of these missense
SNPs were found in the COOH-terminal part of the second
transmembrane domain region within a range of about 50 amino
acids (Fig. S1). In IVM susceptible and intermediate populations
both alleles were identified at all three positions although the
frequency of the minor allele in the susceptible population was
strongly increased in the intermediate populations (Fig. S2 and
Table 1). In contrast, populations with decreased susceptibility
were homozygous and revealed exclusively that allele which was
present at only about 20–25% in the susceptible populations. All
three SNPs caused a change in the deduced amino acid sequence,
i.e. from aspartic acid to asparagine (Asp931Asn), from cysteine to
serine (Cys951Ser) and from tyrosine to histidine (Tyr978His). The
chemical differences according to the scale of Grantham [39]
between these amino acids are 23, 112 and 83, respectively (Table
S6). The first and the last polymorphism were caused by a
substitution at the first position of the codon, while the substitution
of the second amino acid was a result of a change in the second
codon position. A three dimensional model of PeqPgp-11 was
calculated using the ESyPred3D webserver [46] and mouse Pgp-1
(PDB accession no.: 3G5U_A) as template. Fig. S3A reflects the
position of the three substituted amino acids and highlights their
proximity to residues known to be involved in drug binding in the
mouse Pgp. The latter were described to interact with the Pgp
substrates QZ59-SSS, QZ59-RRR or verapamil [40] and the
corresponding amino acids in PeqPgp-11 were identified from a
local alignment of both sequences (Fig. S3B). Interestingly, only
nine out of 27 residues involved in substrate binding are conserved
between both proteins suggesting that there are substantial
differences in the properties of the substrate binding pockets of
both transporters.
Tissue-specific Expression Patterns of pgp mRNAs
Comparison of expression levels for both pgp mRNAs identified
several significant differences. In general, differences in expression
levels were much higher for pgp-16 than for pgp-11 (Fig. 2). For
pgp-11, significantly lower expression was found in the uterus
compared to the female gut, and for the male body wall compared
to the male gut (Fig. 2A). Moreover, expression was higher in male
Figure 1. Maximum likelihood phylogenetic analysis of Pgp
protein sequences from nematodes. Protein sequences were
aligned using ClustalX2 under default conditions. Optimal amino acid
substitution models were determined using Prottest 3.0 before
calculating the most likely tree topology using PhyML3.0.1. The
substitution model LG was used and PhyML was set to optimize the
number of invariant sites, the amino acid frequencies and the C shape
parameter for modelling the distribution of the amino acid substitution
rate categories which were set to eight. Both results of the approximate
likelihood ratio test modified according to Shimodaira and Hasegawa
(before the slash) and of a Bayesian-like transformation of the
approximate likelihood ratio test (after the slash) are shown as branch
supports. As outgroup, Pgp sequences from mouse (Mmu), Drosophila
melanogaster (Dme), Pediculus humanus corporis (Phu), Schistosoma
mansoni (Sma) were used. The complete Pgp protein families of
Caenorhabditis elegans (Cel) and Caenorhabditis briggsae (Cbr) were
included. In addition, available annotated Pgp sequences of Pristionchus
pacificus (Ppa) and of the parasites Ascaris suum (Asu), Brugia malayi
(Bma), Haemonchus contortus (Hco) and Onchocerca volvolus (Ovo) were
used for alignment. Pgp, P-glycoprotein; MDR, multi-drug resistance
protein. The scale bar represents the indicated number of substitutions
per site. Accession numbers for protein sequences in the tree are
provided in Table S5.
doi:10.1371/journal.pone.0061635.g001
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than female gut. The pgp-16 mRNA expression was higher in
male than in corresponding female tissues and in male body wall
than in male gut (Fig. 2B).
Expression Levels of pgp mRNAs in Eggs of Different P.
equorum Populations
Constitutive expression-levels of both Pgps in eggs from the six
populations with different ML susceptibility were measured by
RT-qPCR. All expression levels were normalized to the suscep-
tible P. equorum population from stud-farm A. Variation between
the biological replicates was very small whereas huge differences in
the expression levels of the pgp-11 and pgp-16 transcripts were
observed between the different populations (Fig. 3). However, no
consistent patterns of Pgp-expression between ML susceptible
populations on one hand and populations with decreased IVM
susceptibility on the other hand were observed.
In vitro Effects of IVM on pgp mRNA Expression in Adult
Worms
Adult P. equorum from a phenotypically uncharacterized Polish
field population were cultured in vitro in the presence of 1028 and
1029 M IVM for 18 h before RNA isolation. All worms incubated
in 1028 M IVM died during incubation. In contrast, most worms
incubated in 1029 M IVM survived and RNA was extracted only
from worms that were still motile after 18 h to prevent that
potential degradation of RNA could compromise the analyses.
Real-time RT-PCR did not show any significant differences
between controls and IVM exposed individuals regarding pgp-11
and pgp-16 mRNAs (Fig. 4).
Comparison of a Putatively Resistant and a Random
Group of P. equorum
Two groups of randomly selected male and female worms of
young adult P. equorum were compared to a group of worms of the
same development stage but with an assumed resistant phenotype
due to treatment failure. Sequence comparison using the SeqDoC
method revealed for the random group a genotype corresponding
to the one of the susceptible P. equorum populations described
above. In contrast, the group showing the resistant phenotype
revealed frequencies of the three SNP correlating with decreased
susceptibility between 41.3% and 54.1% (Table 1).
Resistance was associated with a significant 5.9 fold increase of
pgp-11 expression in male worms (p= 0.008) while a 1.5 fold
higher expression in putatively resistant female worms was just not
Table 1. Allele frequencies in different Parascaris equorum populations.
Populationa























































aPopulations from farms are encoded only by letter code used throughout the manuscript. Values were obtained from the area under the curve of the corresponding
pgp-11 sequence chromatograms of P. equorum populations showing different ML susceptibility. All values are given in %.
bNucleotide.
cPutatively resistant pre-adult worms from Czech Republic.
dRandomly selected pre-adult worms from Krakow.
doi:10.1371/journal.pone.0061635.t001
Figure 2. Tissue expression pattern of P. equorum pgp mRNAs.
Expression of pgp-11 (A) and pgp-16 (B) mRNAs was measured in gut,
body wall, and uterus of 5–6 female and male worms. Real-time RT-PCR
was performed on individual worms using actin and gpd-1 mRNA and
18S rRNA as reference genes. Two biological replicates were
investigated for each population and each replicate was analyzed in
two technical repeats of two independent cDNA samples. All individual
values were normalised to the mean of the respective controls.
Whiskers represent minimal and maximal values. A Kruskal-Wallis test
with Dunn’s post hoc test was performed to identify significant
differences between the three female tissues. Mann-Whitney U tests
were conducted to identify differences between the male tissues and
between males and females for the same tissue. ***, p,0.001; **,
p,0.01; *, p,0.05.
doi:10.1371/journal.pone.0061635.g002
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significant (p = 0.056) (Fig. 5A). Moreover, a significant difference
was found by comparing male and female worms within the
random groups showing an 2.7 fold higher expression of Pgp-11 in
female than in male worms (p-value ,0.016), but not by
comparing both genders between putatively resistant worms.
The pgp-16 mRNA expression did not show any significant
differences associated with resistance of worms (Fig. 5B).
Discussion
Anthelmintic resistance in nematodes is an increasing problem
in livestock but is also seen or is suspected to occur in human
parasites such as O. volvulus [4,47] and Trichuris trichiura [48].
During the past years, once very powerful broad-spectrum-
anthelmintics such as IVM had to forfeit their efficacy against
several parasite species. Therefore, it is important to characterize
the mechanisms which are responsible for this development in
order to (I) prolong the activity of existing drugs and (II) be aware
of these mechanisms for the development of novel, resistance-
breaking drugs in the future. ML resistance in nematodes has often
been proposed to be associated with Pgp-mediated drug efflux [3]
and for several organisms, these proteins and their sequences were
already partially characterized. However, this was not yet the case
Figure 3. Expression of pgp-11 (A) and pgp-16 (B) mRNAs in
Parascaris equorum eggs. Expression of mRNAs was compared
between populations showing full (farms A and B1), intermediate
(farms C and D) or decreased (farms B2 and E) ML susceptibility. RNA
was extracted from eggs obtained from five different stables (farms A-
E). Farm B was represented twice, once when IVM was still fully effective
(farm B1) and a second time when efficacy was severely compromised
(farm B2). Real-time RT-PCR was performed in four biological replicates
and two technical replicates. Actin and gpd-1 mRNA and 18S rRNA were
used as reference genes. All individual values were normalized to the
mean of the respective controls. Whiskers represent minimal and
maximal values. A Kruskal-Wallis test with Dunn’s post hoc test was
performed to identify significant differences between the six farms. ***,
p,0.001; *, p,0.05.
doi:10.1371/journal.pone.0061635.g003
Figure 4. Effects of in vitro IVM incubation on Pgp mRNA
expression. Adult male P. equorum (n = 5) were incubated for 18 h in
1028 M IVM (IVM) or only in 1% DMSO as vehicle (contr.). Real-time RT-
PCR was performed on individual worms using actin and gpd-1 mRNA
and 18S rRNA as reference genes. Expression of pgp-11 (open boxes)
and pgp-16 (grey boxes) are shown. At least two cDNA syntheses were
made for each biological replicate and used for two technical replicates
each. All individual values were normalized to the mean of the
respective controls. Whiskers represent minimal and maximal values. No
significant differences were found.
doi:10.1371/journal.pone.0061635.g004
Figure 5. Expression of pgp-11 and pgp-16 mRNAs in pre-adult
Parascaris equorum. A randomly chosen group (n = 5) was compared
with a group where ML treatment failed (n = 5). As a reference,
expression of the actin, gpd-1 and 18S rRNA genes was measured. Real-
time RT-PCR was conducted in duplicate for each sample using two
different cDNAs for each biological replicate. Differences between
randomly selected and putatively resistant worms were identified with
Mann-Whitney U tests. **, p,0.01; *, p,0.05; #, p,0.056.
doi:10.1371/journal.pone.0061635.g005
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for P. equorum, although this nematode showed a decreased
susceptibility against MLs in several studies [23]. It is noteworthy
that for P. equorum, like for most other parasitic nematodes, no
laboratory animal or in vitro life cycle model is available to date.
This is a major constraint for the study of mechanistic or
functional processes in this parasite. Furthermore, such work is
hampered by the very high costs and ethical limitations when
using horses in experimental studies. Accordingly also in the
present study it was only possible to use parasite material derived
from field infections and consequently differing genetic back-
ground as well as only comparatively limited opportunities for
phenotypic characterization.
The two Pgp cDNAs identified in this work provide the first
information about P. equorum multi-drug transporters. It does not
surprise that phylogenetic analyses revealed for both sequences a
close resemblance to amino acid sequences of Pgps from the
phylogenetically most closely related A. suum. However, for these
transporters no further information except for the sequences is
available. Comparison with corresponding sequences of other
nematodes showed also a close relationship of PeqPgp-11 to C.
elegans Pgp-11 as well as to O. volvulus Pgp and Pgp-1 which have
already been linked to ML resistance [21,49]. In order to prevent
any confusion, it should probably be mentioned that both O.
volvolus cDNAs were not designated according to orthology with C.
elegans orthologs. C. elegans Pgp-11 was found to be expressed in the
excretory cell and in the intestine [50]. Similar locations were
identified for the ortholog of P. equorum where the examination of
different tissues for their Pgp expression levels revealed that in
both genders a significantly higher expression was found in the
intestine compared to body wall and uterus. The sequence of
PeqPgp-16 is apparently an ortholog to C. briggsae CBG12969 and
is relatively closely related to C. elegans and C. briggsae Pgp-4 and
Pgp-3. The C. elegans pgp-3 gene has been shown to be involved in
protection against toxic compounds such as colchicine and
chloroquine [7] as well as against bacterial toxins [51]. More
recently, an association between overexpression of C. elegans pgp-4
and IVM resistance was demonstrated [14]. For C. elegans pgp-4,
the excretory cell was identified as the main expression site,
whereas results for C. elegans pgp-3 indicate expression predom-
inantly in the intestine and the excretory cell [50]. Results for P.
equorum pgp-16, revealed a high expression in the body wall
containing not only muscle cells and hypodermis but also the
excretory cell. Further in situ hybridization analyses will be
required to identify the cellular source of pgp-16 mRNA in the
body wall.
Pgps might contribute to the development of resistance by either
overexpression [10,20,52] or changes in their primary structure
that could lead to accelerated transport of anthelmintics.
Comparison of two ML susceptible, two intermediate and two
populations with decreased ML susceptibility revealed only a few
mutations for PeqPgp-16, most of them silent. Regarding pgp-16
expression levels, no consistent up- or down-regulation of pgp-16
correlating with decreased ML susceptibility was found. Further-
more, in another experiment using a phenotypically uncharacter-
ized field population IVM exposure in vitro did also not increase its
expression. We therefore conclude that PeqPgp-16 does not
contribute to decreased ML susceptibility at least in the
populations studied here.
In contrast, corresponding studies on Pgp-11 imply a putative
contribution to ML resistance of this transporter. In particular,
besides several other coding and silent SNPs, three amino acid
substitutions were strongly increased in frequency or exclusively
present in populations with intermediate and decreased ML
susceptibility, respectively.
Aller et al. [40] described the three-dimensional structure of the
mouse Pgp (ABCB1) with drug-binding sites in the internal cavity.
Mapping of these amino acid residues and the three resistance-
correlated exchanges to a calculated 3D model of P. equorum Pgp-
11 revealed that the three amino acid residues are close to or in the
putative drug binding region. Increased IVM affinity of Pgp-11
due to these mutations is an attractive hypothesis that could
explain why such SNPs have apparently been selected in IVM
resistant populations. Further experimental work involving
recombinant P. equorum Pgp-11 from susceptible and resistant
populations and characterization of their transport properties will
be required to corroborate this hypothesis. There are currently no
guidelines from the World’s Association for Advancement of
Veterinary Parasitology (WAAVP) for conducting the FECRT in
P. equorum, in part due to the facts that there is (I) no correlation
between worm burdens and egg counts [53] and (II) a high
variability in egg counts even in samples repeatedly taken from the
same animal [32]. Nevertheless, FECRT data are currently
considered to be the only way to at least roughly estimate
resistance. In particular since there is no standardized protocol for
detection of resistance against ML, the SNPs and expression
differences identified here can well be the basis for development of
molecular tests as previously described for resistance to benzimid-
azoles [54]. In the absence of any validated in vivo or in vitro tests
available for detection of resistance in ascarids, the opportunity to
develop and evaluate molecular tests using the data provided here
might be important also for human diseases such as ascarosis and
toxascarosis. Validating and using the identified SNPs as
molecular markers for resistance using for instance comparison
of systematic comparison of FECRT data and SNP frequencies
(e.g. by pyrosequencing) could solve this problem.
Increased expression of Peqpgp-11 would further substantiate
the view that Pgp-11 contributes to IVM resistance in P. equorum.
However, incubation of worms in vitro for 12 h did not modify
pgp-11 mRNA expression. Moreover, P. equorum eggs were
investigated by real-time RT-PCR, but no correlation between
ML tolerance and pgp-11 mRNA levels was found. In marked
contrast, pre-adult worms obtained from a presumably resistant P.
equorum population showed significant overexpression of pgp-11
mRNA in male and female worms. In addition, the three SNPs
identified in the eggs of other populations with decreased
susceptibility were found with a frequency similar to that found
in the intermediately resistant P. equorum populations. These
findings imply that the susceptibility to MLs in P. equorum can be
dependent on both changes in Pgp-11 primary structure and pgp-
11 expression levels. Further studies involving more adult stages
will reveal whether this gene generally shows higher expression
levels in ML resistant worms.
The reason for the different Pgp-11 expression patterns of the
two development stages might be explained by lower expression
levels of Pgps in earlier development stages than in adults due to
other protective mechanisms. The high tenacity of embryonated
ascarid eggs is probably based on the eggshell constituting an
effective barrier for most compounds. Therefore, exposure to
xenobiotics and need for efflux effectors such as Pgps might be
lower compared to free larvae and adult worms which are in direct
contact to exogenous compounds. Comparison of non-feeding,
relatively resistant third larvae of H. contortus showed similar
results, i.e. no significant differences were found in expression of
nine Pgp mRNAs between a resistant and susceptible strain [16].
These authors suggested, among noting that only constitutive
mRNA levels were under investigation, expression may change
throughout the life cycle. They conclude that developmental stages
living in compartments with the highest risk for an IVM exposure
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require more protection through Pgps than stages without regular
exposure to the drug. Indeed adult worms of O. volvulus were
shown to have higher expression of two Pgp-genes than third stage
larvae [21]. Nevertheless it should be mentioned that for other ML
resistant nematodes such as T. circumcincta significant increases of
the Pgp transcript levels were found throughout the whole life-
cycle especially in the eggs [20]. Kerboeuf et al. [55] described
significantly higher Pgp amounts on the egg-surface of H. contortus
resistant to BZs and IVMs. These results are in apparent
opposition to those reported in this study but the differences
might be explained by different life cycles and differences in the
egg structure between trichostrongylid and ascarid nematodes.
Probably, there are different possible mechanisms to acquire ML
resistance and various species (or even populations) might
therefore differ in their actual resistance mechanisms.
In conclusion, this study suggests involvement of Pgp-11 in the
level of IVM susceptibility in P. equorum. Increase in pgp-11 mRNA
expression was observed in one putatively resistant population.
Most importantly increased frequency of pgp-11 alleles differing in
three SNPs from the predominant alleles in susceptible popula-
tions was observed in several populations with decreased IVM
susceptibility. Bourginat et al. [56,57] identified SNPs in Dirofilaria
immitis Pgps which are correlated to ML susceptibility/resistance.
While one SNP was non-coding, the other caused a conservative
change from lysine to arginine, immediately before the second
nucleotide binding domain. Herein, we describe for the first time
putatively ML resistance associated non-synonymous SNPs
located in substrate binding regions of Pgps. This further
corroborates the hypothesis that MLs select for certain Pgp
genotypes. However, further functional analysis involving recom-
binant expression of both alleles and quantification of ML
transport are required to prove involvement of the herein
described SNPs in ML resistance in P. equorum. To date, molecular
markers for detection of IVM resistance are urgently required and
this study provides promising candidates obtained by comparison
of field populations. Whether the identified SNPs might be useful
as molecular markers for early detection of resistance will be
evaluated by comparing additional field populations differing in
geographical origin and resistance status. Moreover, analysis of
corresponding regions in pgp-11 genes from ML resistant
nematodes of other species will further help to elucidate the
involvement of Pgps in development of IVM resistance in general.
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